Philips is leading the way with meaningful innovations in emergency care that can help you quickly and effectively respond to your patients and influence their overall course of care as never before. As a worldwide leader in emergency care, we draw on our vast network for real-world input to design solutions that matter most to you.
The Philips HeartStart MRx ALS Monitor/Defibrillator, which includes Next-Generation Q-CPR™ and our advanced DXL 12-Lead ECG Algorithm, seamlessly provides advanced patient monitoring capabilities, superb diagnostic measurements, robust STEMI clinical decision support tools, and evidence-based, proven resuscitation therapies in an intuitive, easy-to-use, and rugged design. Philips open systems approach to data management, called “Connected Care”, helps you streamline information to flow from your EMS agency to and throughout the hospital for optimal patient care and operational efficiency.
Advanced STEMI clinical decision support tools for early identification and notification of critical care transports
Whether you have ready access to percutaneous coronary intervention (PCI) or are in a place where transport times may necessitate treatment with thrombolytics, Philips unique total STEMI solution is designed to support and speed the entire 
relay of care starting with the point of discovery when you take the first 12-lead ECG to hand-off at the ED and through the hospital to the Cath Lab and post-procedure care.
Only Philips has the advanced DXL 12-Lead ECG Algorithm, with Clinical Decision Support tools, which takes STEMI clinical decision support to a new level with unique capabilities that enable confident decision-making to help speed triage..
- Pinpoints the STEMI-CA (Culprit Artery) most likely responsible for the acute symptoms, which can assist in directing care in the field and treatment in the Cath Lab.
- Generates Critical Values for four distinct life-threatening conditions – acute MI, acute ischemia, complete heart block, and very fast heart rate – that require immediate clinical attention.
- Provides enhanced Gender-Specific Diagnostic Criteria to improve recognition and interpretation of cardiac symptoms in women.
Philips also offers predictive instruments designed to help support confident decision-making.
- Acute Cardiac Ischemia – Time Insensitive Predictive Instrument (ACI-TIPI) uses the 12-lead ECG to provide a percentage score for predicted probability that the patient is having an Acute Ischemia.
- Thrombolytic Predictive Instrument (TPI) uses the 12-lead ECG to predict patient outcome with and without thrombolytic therapy.
The HeartStart MRx is a key element of Philips total STEMI solution and works with Philips cardiographs, patient monitors, ECG information management systems, and Cath Lab imaging and information solutions to streamline workflow, improve productivity, and raise the quality of your system’s STEMI care.
Connected Care for optimal patient care and operational efficiency
Our goals are optimal patient care and operational efficiency, enabling you to focus more on patient care and less on moving data during treatment and transport. We do this through our open data management approached called, “Connected Care”, which means timely transmission of data, open integration to streamline information flow, and quality debriefing to help you and your medics continuously improve your emergency response services.
- Philips Periodic Clinical Data Transmission (PCDT) enables you to communicate and collaborate with hospital teams for a range of in-coming critical care patients for whom time matters – trauma, stroke, STEMI, pediatric, cardiac. With PCDT, you can automatically document critical event and vitals en route so that you can focus on your patient and the hospital team can be better prepared for the patient’s arrival.
- The HeartStart MRx has flexible, fast, and reliable 12-lead transmission capabilities so you can send data using your choice of technologies to wherever – ED, Cath Lab, cardiologist’s smart phone - you need it to go to begin the next level of care, saving valuable time and tissue.
- HeartStart Event Review Pro captures and stores the entire code for post-event review to help your team reach its full potential for saving more lives. This breakthrough application provides a robust, insightful view of a resuscitation event, along with built-in, easy-to-use navigation to pinpoint areas in a specific patient's code event for learning and improvement.
- Reliable and trackable automated download and delivery solutions mean no files or data are left behind and reduces medic involvement in mundane administrative tasks so they can focus on more important activities.
- Only the HeartStart MRx moves data at LAN speed, which enables rapid downloads and faster device return to service times.
- Automatic time setting ensures the HeartStart MRx is in sync with the system of record from 911 call to device on.
Superb, advanced monitoring capabilities
The HeartStart MRx provides you with advanced monitoring capabilities to help better assess your critical care patients. Key monitoring parameters include:
- Enhanced DXL 12-Lead ECG Algorithm that shows all 12 leads on screen and unfiltered to ensure a reliable 12 lead is acquired
- ST/AR Basic™ arrhythmia detection for 10 rhythm disturbances and irregularities FAST- SpO2 (Fourier Artifact Suppression Technology)
- Microstream® Capnography (etCO2)
- Continuous temperature monitoring (core and skin) for post-resuscitation hypothermia protocols
- Invasive pressures (2 channels)
- Noninvasive blood pressure (NBP)
- Vital signs trending
- Audio recording
Proven resuscitation therapies to help return people to active living
Philips evidence-based, proven resuscitation therapies are designed to work together to help you give sudden cardiac arrest (SCA) patients the best chance of surviving and returning to active living.
- SMART Biphasic therapy has been rigorously studied, as Philips pioneered external biphasic defibrillation, and is supported by substantial peer-reviewed, published data. It has been clinically proven to deliver high first shock efficacy for long-downtime SCA patients, as well as to effectively defibrillate across the full spectrum of patients, including those considered “difficult-to-treat.”1-5
- Next-Generation Q-CPR measurement and feedback tool is supported by more published research than any other CPR quality improvement tool. It has been demonstrated to improve CPR and patient outcomes.6
- Quick Shock delivers therapy in just 8 seconds (typical) after chest compressions. Delivering a shock quickly after chest compressions is critical as the benefits of CPR to deliver blood to vital organs dissipate in seconds.7,8
- Therapeutic Hypothermia has been shown to improve outcomes when delivered early after an ischemic event.9,10,11 The MRx provides continuous temperature monitoring and trending to support pre-hospital cooling protocols.
Built tough, reliable and ready for action
For whatever you face in a day, the HeartStart MRx is built to be tough and ready for action. The HeartStart MRx is designed to meet stringent test requirements including spraying water, military helicopter vibration, mechanical shock, one-meter drop, electro-magnetic compatibility, and extreme environmental conditions (temperature, humidity and altitude). In addition, the same MRx model that we ship to all EMS customers has passed an extensive battery of tests, performed by the US military, to achieve aeromedical air-worthiness certification. These military-level tests include: baseline performance and durability, electrical safety, vibration, electro-magnetic compatibility, climate, altitude, rapid decompression, explosive atmosphere, acceleration, and in-flight performance evaluations.
- Defibrillation as easy as 1-2-3
1. Select energy to choose appropriate dosage
2. Charge button charges the defibrillator in <5 seconds
3. Press shock button to deliver therapy - Large color display shows 4 waveforms and numerics, or view all 12 leads at once with the 12-lead acquisition option.
- Normal or high-contrast view for easy viewing in sunlight conditions.
- 10 hours of monitoring with two fully charged batteries.
- Ready-for-use indicator flashes to signal that ample power exists to monitor and deliver a shock.
- Automated self-tests that run hourly, daily and weekly. Easy-to-run operational checks.
- Color-coded monitoring ports for easy identification; ports match Philips patient monitors for easy hand-off.
Integration and upgrades made easy
Ease of use is the hallmark of all Philips defibrillators and the HeartStart MRx is no exception. Training your medics to use the HeartStart MRx is straightforward due to its intuitive and easy-to-use design. Once the HeartStart MRx becomes part of your system, it can be easily upgraded in the field so that you receive the benefits of Philips advancements now and into the future without increasing the size of your device.
References
1. Schneider T, Martens PR, Paschen H, et al. Multicenter, randomized, controlled trial of 150-J biphasic shocks compared with 200- to 360-J monophasic shocks in the resuscitation of out-of-hospital cardiac arrest victims. Circulation. 2000;102:1780-1787.
2. Page RL, Joglar JA, Kowal RC, et al Use of automated external defibrillators by a U.S. airline. New England Journal of Medicine. 2000;343:1210-1216.
3. White RD, Blackwell TH, Russell JK, Jorgenson DB. Body weight does not affect defibrillation, resuscitation or survival in patients with out-of-hospital biphasic waveform defibrillator. Critical Care Medicine. 2004; 32(9) Supplement: S387-S392.
4. White RD, Blackwell TH, Russell JK, Snyder DE, Jorgenson DB. Transthoracic impedance does not affect defibrillation, resuscitation or survival in patients with out-of-hospital cardiac arrest treated with a non-escalating biphasic waveform defibrillator. Resuscitation. 2005 Jan; 64(1):63-69.
5. Hess EP, Russell JK, Liu PY, et al. A high peak current 150-J fixed-energy defibrillation protocol treats recurrent ventricular fibrillation (VF) as effectively as initial VF. Resuscitation. 2008 Oct;79(1):28- 33.
6. Edelson DP, Litzinger B, Arora V, et al. Improving in-hospital cardiac arrest process and outcomes with performance debriefing. Archives of Internal Medicine. 2008;168(10):1063-1069.
7. Yu T, Weil MH, Tang W, et al. Adverse outcomes of interrupted precordial compression during automated defibrillation. Circulation. 2002; 106:368-372.
8. Eftestol T, Sunde K, Steen PA. Effects of interrupting precordial compressions on the calculated probability of defibrillation success during out-of-hospital cardiac arrest. Circulation. 2002;105:2270-2273.
9. Abella, B et al. "Intra-Arrest Cooling Improves Outcomes in a Murine Cardiac Arrest Model", Circulation. June 8, 2004. pg 2790.
10. Nozari, A. et al "Critical time window for intra-arrest cooling with cold saline flush in a dog model of cardiopulmonary resuscitation" Circulation. 2006 Jun 13; 113(23):2690-6.
11. Tanimoto, H et al "Rapidly Induced Hypothermia with extracorporeal lung and heart assist improves the neurological outcome after prolonged cardiac arrest in dogs" Resuscitation. 2006 Nov 9. PMID: 17097794.
Q-CPR is a trademark of Laerdal Medical.